PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40123P00426Sole-source FFP 5-year purchase order for — Biomedical Research Alliance of New York LLC

Biomedical Research Alliance of New York LLC holds $1.0M across 11 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 2 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. PoP ended Sep 29, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs
Awarding office
Biomedical Research Alliance of New York LLC
Recipient
Sep 29, 2026
PoP end
$261K
Obligated
$343K
Potential
611430
NAICS
U004
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75F40123P00426
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentBiomedical Research Alliance of New York LLC
CAGE7JXU8
UEIL1K7UFDEG5N5
NAICS611430

No full NAICS 611430 intel page yet. Browse NAICS intelligence

PSCU004
Place of performanceSILVER SPRING MD
Pricing typeFirm Fixed Price
Extent competedNot Competed Under SAP
Related solicitation75F40123Q00415
PoP startSep 20, 2023
PoP end (current)Sep 29, 2026
PoP end (w/ options)Sep 29, 2028
Obligated$261K
Current value$343K
Potential value$343K

Sole-Source, FFP, 5-Year Purchase Order for Web-Based Training Services is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by Biomedical Research Alliance of New York LLC. Estimated value $343K ($261K obligated). Current period of performance ends Sep 29, 2026 (potential Sep 29, 2028). Last award drew 1 bidder. Place of performance: SILVER SPRING MD. Related solicitation 75F40123Q00415.

Sole-source, ffp, 5-year purchase order for web-based training services. Latest action is a modification.

Recompete timing

Public
● Past PoP end (18 days ago)

Current PoP ended Sep 29, 2026 (18 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Want the durability read on 75F40123P00426? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Biomedical Research Alliance of New York LLC — $1.0M obligated across 11 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($1.0M) · all agencies
Department of Defense (DOD)$597K · 60%Department of Health and Human Services (HHS)$395K · 40%Department of Veterans Affairs (VA)$13K · 1%Department of Homeland Security (DHS)$5K · 1%
Open full company profile →

Related awards

Same incumbent
N0001422C4002
ORGANIZATIONAL BASE SUBSCRIPTION (WEB-BASED TRAINING) IN THE AREA OF HUMAN SUBJECT RESEARC…
$855K
Mar 19, 2027
HT001122P0010
BIOSAFETY AND BIOSECURITY TRAINING SUBSCRIPTION
$135K
Jun 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40123P00426?

75F40123P00426 (Sole-source FFP 5-year purchase order for) is a Fda Office Of Acq Grant Svcs award with a potential value of $343K, currently held by Biomedical Research Alliance of New York LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40123P00426?

Fda Office Of Acq Grant Svcs awarded 75F40123P00426 to Biomedical Research Alliance of New York LLC (potential $343K).

Who is the incumbent on 75F40123P00426?

Biomedical Research Alliance of New York LLC is the incumbent with $1.0M across 11 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.

When does Biomedical Research Alliance of New York LLC’s 75F40123P00426 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40123P00426? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40123P00426